Ignite Creation Date:
2025-12-25 @ 4:54 AM
Ignite Modification Date:
2026-02-03 @ 4:35 AM
Study NCT ID:
NCT01312818
Status:
TERMINATED
Last Update Posted:
2017-12-28
First Post:
2011-03-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bortezomib, Vorinostat and Dexamethasone for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)
Sponsor:
Masonic Cancer Center, University of Minnesota
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2008LS113
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |